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W
ITH persons aged ≥70 years representing the fastest 
growing segment of the U.S. population (1), preventing 
disability and maintaining independence throughout later life 
is an important public health goal (2,3). Mobility and activities 
of daily living are necessary for maintaining basic independent 
functioning (4,5). The inability to perform these tasks is a 
critical threshold, conferring increased risk of illness, insti-
tutionalization, reductions in quality of life, and death (6,7).
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Background. As the number of older adults in the United States rises, maintaining functional independence among 
older Americans has emerged as a major clinical and public health priority. Older people who lose mobility are less likely 
to remain in the community; demonstrate higher rates of morbidity, mortality, and hospitalizations; and experience a 
poorer quality of life. Several studies have shown that regular physical activity improves functional limitations and inter-
mediate functional outcomes, but definitive evidence showing that major mobility disability can be prevented is lacking. 
A Phase 3 randomized controlled trial is needed to fill this evidence gap.
Methods.  The Lifestyle Interventions and Independence for Elders (LIFE) Study is a Phase 3 multicenter randomized 
controlled trial designed to compare a supervised moderate-intensity physical activity program with a successful aging 
health education program in 1,600 sedentary older persons followed for an average of 2.7 years.
Results.  LIFE’s primary outcome is major mobility disability, defined as the inability to walk 400 m. Secondary 
outcomes include cognitive function, serious fall injuries, persistent mobility disability, the combined outcome of major 
mobility disability or death, disability in activities of daily living, and cost-effectiveness.
Conclusions.  Results of this study are expected to have important public health implications for the large and growing 
population of older sedentary men and women.
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Physical inactivity is one of the strongest predictors of 
physical disability in elders (8,9). Furthermore, exercise 
may benefit many conditions that underlie disability in 
older adults, including risk of falls (10–13), hip fracture 
(14,15), cardiovascular disease (16,17), respiratory diseases 
(18), cancer (19), diabetes (17,20,21), osteoporosis (22–24), 
low fitness and obesity (25,26), sleep–wake disturbances 
(27),  depression  (28,29),  and  dyspnea  and  ventilatory   
capacity (30,31). In longitudinal studies, regular physical 
activity (PA) is associated with extended longevity and 
reduced  risk  of  physical  disability  (32–37).  However,   
observational studies cannot establish a causal association 
between exercise participation and reduced disability because 
the differences between individuals who choose to exercise 
and those who do not can never be fully adjusted for.
Several studies have demonstrated the beneficial effects of 
structured exercise programs on functional outcomes in older 
adults (26,38–41). Despite these results, it remains unclear 
whether the positive effects of regular exercise can be sus-
tained for a sufficient duration of time or whether exercise can 
be maintained at an adequate intensity to prevent a clinically 
meaningful disability outcome, thereby prolonging indepen-
dence. Additionally, it is currently not established whether 
comparable beneficial effects on physical function and dis-
ability can be achieved through a structured successful aging 
(SA)  health  education  intervention.  Finally,  although   
evidence from short-term clinical trials supports the potential 
of PA and exercise to benefit brain health (42–48), long-term 
clinically meaningful effects of PA or health education on 
cognitive function have not been established (49).
Because of these gaps in knowledge, a cooperative agree-
ment between the National Institute on Aging with addi-
tional support from the National Heart, Lung, and Blood 
Institute and several academic institutions was established 
to conduct the Lifestyle Interventions and Independence for 
Elders (LIFE) Study. The present study was based on the 
conduct of a successful pilot study (LIFE-P) in which we 
successfully gathered preliminary data to accurately estimate 
the required sample size for the current trial, demonstrated 
the feasibility of recruitment, confirmed the adherence and 
safety of the intervention, finalized the choice of the primary 
outcome, refined the outcome assessments, and optimized 
the organizational infrastructure (50–53). The LIFE Study, 
a Phase 3 multicenter randomized controlled trial, was   
designed to compare a supervised moderate-intensity PA pro-
gram with a SA health education program on the incidence 
of major mobility disability (the inability to walk 400 m) in 
sedentary older persons with objectively measured functional 
limitations who are followed for an average of 2.7 years.
Primary Research Outcome
The primary goal of the LIFE Study is to compare in 
1,600 sedentary older persons the long-term effect of a 
moderate-intensity PA program with a SA health education 
program on the incidence of major mobility disability 
defined as the inability to walk 400 m.
Methods
Overview
One thousand six hundred sedentary older adults are 
being recruited at eight field centers which include the 
following:  University  of  Florida,  Gainesville,  Florida; 
Northwestern University, Chicago, Illinois; Pennington 
Biomedical  Research  Center,  Baton  Rouge,  Louisiana; 
University of Pittsburgh, Pittsburgh, Pennsylvania; Stanford 
University, Stanford, California; Tufts University, Boston, 
Massachusetts; Wake Forest University, Winston-Salem, 
North Carolina; and Yale University, New Haven, Connecti-
cut. The Administrative Coordinating Center is housed at 
the University of Florida with the Data Management, Anal-
ysis and Quality Control Center (DMAQC) located at Wake 
Forest University School of Medicine.
Eligibility
The LIFE Study eligibility criteria were designed to 
target older persons (age 70–89) who (a) are sedentary, as 
defined as spending less than 20 min/wk in the past month 
getting regular PA and reporting less than 125 min/wk of 
moderate PA (54); (b) are at high risk for mobility disability 
based on objectively assessed lower extremity functional 
limitations assessed by the Short Physical Performance 
Battery (SPPB; score of ≤9) (55,56); (c) can walk 400 m in 
15 minutes without sitting, leaning, or the help of another 
person; and (d) can safely participate in the intervention 
(Table 1). This represents a large segment of the older popu-
lation in which successful prevention of mobility disability 
through a lifestyle intervention would have a major public 
health impact (57). All study procedures have been approved 
by the Institutional Review Boards of all participating centers.
Recruitment
Approximately 200 participants are being recruited at 
each field center for a 21-month period with a goal of 
including at least 22.5% minorities. The researchers aim to 
recruit at least 720 participants (45%) with a baseline SPPB 
score of ≤7 to enrich the study with higher-risk participants. 
Each  field  center  has  a  site-specific  recruitment  plan.   
Recruitment strategies include newspaper; radio and television 
advertisements; direct mailings to age-eligible residents; 
and presentations at health fairs, senior centers, medical 
clinics, and churches (51).
Screening and Randomization
Potential participants are screened by telephone. Those 
who remain eligible are invited to attend a group or individual 
prescreening visit during which the LIFE Study is presented FIELDING ET AL. 1228
in a lecture or individual format. Following a question and 
answer session, attendees are invited to review and sign a 
prescreening consent form. Those still eligible after admin-
istration of the SPPB and the Community Healthy Activities 
Model Program for Seniors (CHAMPS-18) PA question-
naire (54) are invited to attend a first screening visit. Because 
many potential participants are excluded based on their 
SPPB and CHAMPS-18 questionnaire scores, the pre-
screening visits provide an efficient mechanism to identify 
individuals who are not eligible for LIFE. At first and sec-
ond screening visits, medical and functional exclusions are 
assessed. After eligibility is confirmed, participants are 
randomly assigned (1:1 ratio) using a web-based system to 
either the PA or SA intervention.
Study Measures
Table 2 lists the outcomes measured at first and second 
screening visits and during follow-up. All assessment per-
sonnel are masked to randomization assignment.
Primary Study Outcome
Four hundred–meter walk test.—After careful consider-
ation, the time to the onset of major mobility disability was 
selected as the primary outcome. The objective component 
of the major mobility disability outcome is defined as the 
inability to complete a 400-m walk test within 15 minutes 
without sitting, leaning against the wall, or the assistance of 
another  person  or  walker.  Individuals  who  complete  the 
walk in more than 15 minutes have an extremely slow pace 
(<0.45 m/s), which would make their walking capacity of 
little utility in daily life (58). Major mobility disability is 
assessed every 6 months on a 20-m walking course. In addi-
tion to the researchers’ primary outcome, several secondary 
and tertiary outcomes are evaluated.
Secondary Study Outcomes
Cognitive assessment.—Cognitive function is assessed 
at baseline and at 24 months. The cognition secondary 
Table 1.  Inclusion or Exclusion Criteria
Inclusion criteria
  • Age 70–89 years
  • Summary score <10 on the Short Physical Performance Battery (score ranges from 0 [poorest performance] to 12 [best])
  • Sedentary lifestyle defined by ≤125 min of activity per week on the CHAMPS-18 questionnaire
  • Able to complete the 400-m walk test within 15 minutes at baseline without sitting, leaning, using a walker, or the help of another person
  • Willingness to be randomized to either intervention group
Exclusion criteria
  • Unable or unwilling to give informed consent or accept randomization in either study group
  • Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
  • Consumption of more than 14 alcoholic drinks per week
  • Plans to relocate out of the study area within the next 2 years or plans to be out of the study area for more than six consecutive weeks in the next year
  • Self-reported inability to walk across a room
  • Another member of the household is a participant in the LIFE Study
  • Nursing home residence
  • Difficulty communicating with study personnel due to speech or language or hearing problems
  • Modified Mini-Mental State Examination (3MSE) below 2 SDs of education- and race-specific norms 
  • Participation in LIFE Pilot study
  • Severe arthritis, such as awaiting joint replacement, that would interfere with the ability to participate fully in either study arm
  •   Cancer requiring treatment in the past 3 years, except for nonmelanoma skin cancers or cancers that have an excellent prognosis (eg, early-stage breast or prostate cancer)
  • Lung disease requiring regular use of corticosteroids or of supplemental oxygen
  •   Cardiovascular disease (including NYHA Class III or IV congestive heart failure, clinically significant valvular disease, history of cardiac arrest, presence of an 
implantable cardiac defibrillator, or uncontrolled angina)
  • Parkinson’s disease or other progressive neurological disorder
  • Renal disease requiring dialysis
  • Chest pain, severe shortness of breath, or occurrence of other safety concerns during the baseline 400-m walk test
  •   Other medical, psychiatric, or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability to follow 
either the intervention or the successful aging protocol
  • Other illness of such severity that life expectancy is less than 12 months
  • Clinical judgment concerning safety or noncompliance
Temporary exclusion criteria
  • Uncontrolled hypertension (systolic blood pressure > 200 mmHg diastolic blood pressure > 110 mmHg)
  • Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent hypoglycemia
  • Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months
  •   Serious conduction disorder (eg, third-degree heart block), uncontrolled arrhythmia, new Q waves within the past 6 months or ST-segment depressions (>3 mm) 
on the ECG
  • Myocardial infarction, major heart surgery (ie, valve replacement or bypass surgery), stroke, deep vein thrombosis, or pulmonary embolus in the past 6 months
  • Current participation in physical therapy or cardiopulmonary rehabilitation
  • Current enrollment in another randomized trial involving lifestyle or pharmaceutical interventions
Note: ECG = electrocardiogram; LIFE = Lifestyle Interventions and Independence for Elders. LIFESTYLE INTERVENTIONS AND INDEPENDENCE FOR ELDERS STUDY 1229
outcome is powered upon the Digit Symbol Substitution 
test  and  the  Hopkins Verbal  Learning  test.  The  Digit 
Symbol Substitution test is a measure of attention and per-
ceptual speed in which participants are given a series of 
numbered symbols and then asked to draw the appropriate 
symbols below a list of random numbers (59). The Hopkins 
Verbal Learning test is a 12-item learning and memory test 
designed for brief easy administration (60). Additional cog-
nitive assessments include the Modified Mini-Mental Status 
Examination (3MSE) measuring general cognitive function 
(61); the Eriksen flanker task measuring response inhibition 
(62); the N-Back test measuring working memory (63,64); 
and the Task-Switching test measuring attentional flexibility 
(65,66).
Serious fall injury.—Serious fall injuries include only 
those falls that result in a clinical fracture (nonvetebral), 
lead  to  hospitalization,  or  both.  Serious  fall  injuries  are   
assessed by participant interview every 6 months. Other 
falls and fractures are captured at this interview as well.
Disability questionnaire.—Disability is assessed with the 
Pepper Assessment Tool for Disability (67,68). This ques-
tionnaire contains 19 items covering 3 domains: (a) basic 
activities of daily living (moving in and out of a chair, 
moving in and out of a bed, gripping with hands, using 
toilet, dressing, getting in and out of a car, walking across a 
small  room,  and  bathing);  (b)  mobility  (walking  several 
blocks, lifting heavy objects, walking one block, lifting or 
carrying 10 lbs, climbing several flights of stairs, climbing   
one flight of stairs, and walking a quarter of a mile); and (c) 
instrumental  activities  of  daily  living  (light  housework, 
participating in community activities, managing money, 
visiting with relatives or friends, using the telephone, and 
taking care of a family member).
Cost-effectiveness analysis.—The self-administered ver-
sion of the Quality of Well-Being scale is used to assess 
general quality of life for the planned cost–utility analyses 
(69,70). The assessment covers symptoms, acute and chronic 
conditions and psychological well-being.
Health care utilization is assessed at baseline and every 
6 months using a self-administered questionnaire. The 
measure consists of 12 questions that ask about the fre-
quency of specific types of health care utilization includ-
ing days hospitalized, emergency care, urgent care, primary 
care, telephone calls, prescriptions, and medical equip-
ment. Health care costs are calculated by multiplying the 
frequency of each service by the prevailing community 
charge.
Table 2.  Schedule of Outcome Assessments
Assessments Baseline 6 months 12 months 18 months 24 months 30 months 36 months 42 months Closeout
Primary outcome
  400-m walk test × × × × × × × × ×
Secondary outcomes
  Cognitive battery × ×
  Serious falls assessment × × × × × × × × ×
  Disability questionnaire × × × × × ×
  Cost-effectiveness analysis × × × × × × × ×
Tertiary outcomes
  Additional cognitive measures × ×
  SPPB × × × × × ×
  Sleep–wake disturbances × × × ×
  Dyspnea and ventilatory capacity × × × ×
  Cardiopulmonary events or  
    hospitalizations
× × × × × × × × ×
Additional measures
  Demographic information ×
  Medical and hospital admission history ×
  Physical examination or body height ×
  Medication inventory × ×
  Blood pressure or radial pulse × × × ×
  ECG × × ×
  Mobility Assessment Tool × × ×
  CHAMPS-18 × × × × × ×
  Accelerometry × × × ×
  Process measures × × ×
  Ankle Brachial Index × × ×
  Claudication questionnaire × ×
  Blood or urine samples × × × ×
  Grip strength × ×
  Health-Related Quality of Life × × ×
Note: ECG = electrocardiogram; SPPB = Short Physical Performance Battery.FIELDING ET AL. 1230
Tertiary Outcomes
Incident dementia is assessed through a screening proce-
dure with prespecified scoring cutoffs for the 3MSE (61). 
Participants who demonstrate possible early cognitive im-
pairment or dementia at 24 months undergo a more compre-
hensive cognitive assessment. Incident dementia, cognitive 
impairment without dementia, or normal cognitive function 
is adjudicated in a standardized manner by an expert panel.
Short Physical Performance Battery.—The SPPB is a 
summary performance measure consisting of 4 m walking 
velocity at usual pace, a timed repeated chair stand, and 
three increasingly difficult standing balance tests (71). Each 
performance measure is assigned a categorical score ranging 
from 0 (inability to complete the test) to 4 (best perform-
ing). A summary score ranging from 0 (worst performers) 
to 12 (best performers) is calculated by summing the three 
component scores.
Additional tertiary outcomes.—Additional tertiary out-
comes  include  measures  of  sleep–wake  disturbances:   
Epworth  Sleepiness  scale  (72),  Insomnia  Severity  Index   
(73), Pittsburgh Sleep Quality Index (74), and Berlin Ques-
tionnaire (75). Two questions are administered regarding 
napping behavior and the use of caffeine and energy drinks. 
Ventilatory capacity and dyspnea are assessed using hand-
held spirometry; a modified version of the ATS-DLD-78-A 
questionnaire that assesses respiratory symptoms, prior car-
diopulmonary illnesses, occupational history, and smoking 
exposure (76); and the Borg index for dyspnea, which is 
administered immediately upon completion of the 400-m 
walk (77). Cardiovascular events to be assessed as tertiary 
outcomes include hospitalization for acute myocardial in-
farction or angina, stroke, congestive heart failure, peripheral 
artery disease, coronary artery bypass surgery, abdominal 
aortic aneurysm, carotid endarterectomy, inpatient or outpa-
tient coronary or lower extremity angioplasty, and car-
diovascular death. Pulmonary outcomes include hospital 
admission for COPD or asthma, bronchitis, and pneumonia. 
Medical records are obtained and reviewed blinded to group 
assignment, and adjudication is made by an expert committee.
Study Interventions
Participants are randomly assigned to the PA intervention 
or to the SA program. The behavior change promoted   
in both interventions is based on social cognitive theory 
principles combined with a group-mediated approach for 
promoting PA among older adults (78,79). Concepts from 
social cognitive theory are combined with strategies derived 
from applications of the Transtheoretical Model (eg, con-
sciousness raising, building of self-efficacy for participation, 
informational exchange, and other cognitive approaches in 
the preparation and action phases early in the program, sup-
plemented with ongoing reinforcement, social support, and 
related behavioral approaches that are continued through 
the later phases of the program). These are applied by using 
a tailored social problem-solving approach. Participants 
in  both  groups  receive  an  initial  individual  45-minute 
face-to-face  introductory  session  by  a  health  educator 
who describes the PA or SA intervention, communicates 
expectations, and answers questions.
PA intervention.—The PA intervention that encompasses 
both structured exercise and PA includes aerobic, strength, 
flexibility,  and  balance  training  and  is  designed  to  be   
performed at the center (two times per week) and at home 
(Table 3). PA goals are individualized based on each par-
ticipant’s level of physical fitness. Goals are modified in 
response to illness, injury, or physical symptoms.
Walking is the primary mode of PA, given its wide-
spread  popularity  and  ease  of  administration  across  a 
broad segment of the older adult population (80,81). Each 
session  is  preceded  by  a  brief  warm-up  (walking  at  a 
slow  pace)  and  followed  by  a  brief  cooldown  period. 
Three times weekly, participants complete a 10-minute 
leg-strengthening  program  with  ankle  weights  (knee   
extension, knee flexion, squats, side leg raises, and toe 
raises) after walking exercise followed by a brief lower 
extremity stretching routine.
Instructional materials are supplied to reinforce the strength 
training occurring during center-based instruction, so that it 
can be generalized to the home environment. Balance train-
ing is introduced during the adoption phase as a complement 
to the aerobic and strength training (82). Progressive exer-
cises (levels I–V) that challenge balance by first decreasing 
arm support, then decreasing base of support, and finally   
increasing the complexity of the movements are included. In 
addition, the intervention involves encouraging participants 
to increase all forms of PA throughout the day. This may   
include activities such as leisure sports, gardening, use of stairs 
as opposed to escalators, and leisurely walks with friends.
Intensity of training.—The participants are introduced to 
the PA intervention in a structured way such that they begin 
with lighter intensity and gradually increase intensity over 
Table 3.  Physical Activity Intervention Schedule
Phase Center-Based Physical Activity Home-Based Physical Activity
Adoption: Weeks 1–52 Two times each week; progressing to 40 min walking,  
  10 min strength training, 10 min balance
One time per week (weeks 1–4); two times per week  
  (weeks 4–8); up to three to four times per week (weeks 8–52)
Maintenance: Weeks 53 to end Two times each week; progressing to 40 min walking,  
  10 min strength training, 10 min balance
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the first 2–3 weeks of the intervention. LIFE promotes 
walking for exercise at a moderate intensity and relies on 
ratings of perceived exertion as a method to regulate PA in-
tensity. Using the Borg scale (77), which ranges from 6   
to 20, participants are asked to walk at an intensity of 13 
(activity  perception  “somewhat  hard”).  Lower  extremity 
strengthening exercises are performed (2 sets of 10 repeti-
tions) at an intensity of 15–16 using Borg’s scale for the 
strength-training component.
Contact  mode  and  frequency.—The  PA  intervention 
includes a weekly walking goal of 150 minutes, consistent 
with the 2008 Physical Activity Guidelines for Americans 
report (83). This goal is approached progressively across 
the first 3 months.
SA intervention.—The SA intervention provides age-
specific  health  information  about  SA.  SA  consists  of 
workshops on topics relevant to older adults (eg, how to ef-
fectively negotiate the health care system, how to travel 
safely, recommended preventive services and screenings at 
different ages, where to go for reliable health information, 
nutrition, etc.). An informational brochure on PA is presented 
to all participants during the first SA intervention session. 
However, during the subsequent SA session, topics related 
to  PA  are  purposely  avoided. The  program  includes  a   
5- to 10-minute instructor-led program of upper extremity 
stretching or flexibility exercises. The SA meets weekly for 
the first 26 weeks of the intervention. From week 27 on, SA 
is offered two times per month with required participation 
at least once per month.
Statistical Considerations
The primary study outcome of the LIFE Study will be 
tested based on an intent-to-treat approach using a two-
tailed 0.05 significance level. To compare intervention arms 
with respect to the distribution of times until the first post-
randomization occurrence of measured inability to com-
plete a 400-m walk in 15 minutes, the researchers will use a 
likelihood ratio test from a stratified Cox model using field 
center and gender as strata. Failure time will be measured 
from the time of randomization, and for those that do not 
fail the 400-m walk, follow-up will be censored at the time 
of the last 400-m walk assessment. Based on the results of 
LIFE-P and the Health Aging and Body Composition study 
follow-up data, the researchers projected an initial annual 
incidence rate of 18% that increases, on average, to 21% 
after  2  years  of  follow-up  (7,50).  The  researchers  will   
assume that loss to follow-up accumulates at 8% per year 
throughout LIFE and this is factored into all projections   
of power. Under these assumptions, the LIFE Study is 
projected to have >80% power to detect relative effect sizes 
>21% and >90% power to detect relative effect sizes >24% 
assuming uniform recruitment of 1,600 participants for a 
period of 21 months. To provide perspective for these effect 
sizes, based on the preliminary data collected for a period of 
1 year of follow-up in LIFE-P, a 29% (hazard ratio = 0.71; 
95% CI 0.44–1.20) relative reduction in mobility disability 
was observed in the PA group.
All secondary outcomes will be analyzed using an intent-
to-treat  approach.  Comparisons  between  intervention 
groups will be performed using a two-tailed 0.05 signifi-
cance level. Analysis of covariance, with adjustment for 
field center, gender, and the baseline value of the outcome, 
will be used to assess the relative effect of randomization 
assignment on cognitive function measures (ie, Digit Sym-
bol Substitution test and Hopkins Verbal Learning test ). 
Survival analysis (stratified Cox model using gender as a 
stratifying factor) will be used to compare the intervention 
groups with respect to the distribution of time until the first 
postrandomization occurrence of a serious fall injury. Due 
to the expected small number of injurious falls, the researchers 
have chosen not to use clinical center as a stratification fac-
tor in this analysis. A comparison of intervention groups 
with respect to the distribution of time until the first post-
randomization occurrence of major mobility disability or 
death will use a stratified Cox model identical to that used 
for the primary outcome. The effect of the intervention on 
persistent major mobility disability, defined as having major 
mobility disability at two consecutive assessments, will 
be analyzed using transitional models for categorical end-
points. The researchers will use generalized estimating 
equations to assess the relative effect of randomization to 
the intervention on the proportion of 400-m walk failures 
over  time. Activities  of  daily  living  endpoints  will  be   
analyzed using mixed-effects models with variables in the 
model representing field centers, gender, a follow-up time 
effect, the baseline outcome, and the intervention effect.
Cost-effectiveness analyses will follow the guidelines of 
the Panel of Cost-Effectiveness in Health and Medicine. 
The ratio of direct costs of the PA intervention to the amount 
of quality-adjusted life years produced will be calculated. 
Health care costs will be estimated, and differences between 
intervention groups will be calculated to examine whether 
any cost offset may occur. Decision modeling will be used 
to estimate long-term cost-effectiveness beyond the 1-year 
time horizon for which data collection is planned. Future 
health care costs will be discounted at a rate of 3% for any 
calculations or projections beyond the first year of follow-up.
Participant safety.—Participant safety is a priority, and 
multiple strategies are employed to minimize adverse events 
associated with participation in the study. The screening 
process ensures that participants are safe to participate in 
the planned intervention and assessments. Adverse events 
are closely tracked with particular emphasis on events that 
could be associated with participation in the study. A Data 
Safety Monitoring Board regularly reviews all adverse 
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Study Management
Field  centers.—Each  LIFE  field  center  recruits  and 
enrolls participants, administers the interventions, ensures 
retention and adherence of participants, performs all assess-
ments, and enters data into the web-based data entry sys-
tem. Centralized study training and staff certification was 
completed in January 2010, and all field centers participate 
in biannual site visits.
Steering Committee.—The Steering Committee provides 
study oversight and includes the study coprincipal investi-
gators; field center, coordinating center, and analysis center 
principal investigators; selected additional investigators 
from these centers; and the National Institutes of Health 
Project Staff. The Steering Committee develops the man-
uals of operations and procedures, supervises the execution 
of the trial, generates and approves study policies, and plans 
and drafts study-related publications. The Steering Com-
mittee  has  charged  the  following  subcommittees  with 
specific aspects of the trial: the Measurement and Event 
Adjudication Committee; the Interventions and Operations 
Committee; the Recruitment, Adherence, and Retention 
Committee; the Medical Safety Committee; the Emerging 
Science Committee; and the Publications and Presentations 
Committee. All major scientific decisions are advised by the 
relevant subcommittees and ratified by majority vote of the 
Steering Committee.
Administrative Coordinating Center.—All administrative 
and coordination functions are conducted by the Adminis-
trative Coordinating Center at the University of Florida.
Data Management, Analysis and Quality Control Center.—
The data are managed and analyzed by the DMAQC. The 
DMAQC is responsible for the development of internet-
based computerized data entry screens. A web browser ap-
plication is used to manage screening, randomization, and 
follow-up visits. Analyses and development of data moni-
toring reports are performed centrally by DMAQC statisti-
cians. Only members of the DMAQC, Data Safety Monitoring 
Board, and National Institutes of Health program office 
have access to unmasked reports.
Cognition Coordinating Center.—Training, quality control, 
and adjudication of cognitive classification are managed by 
the Kulynych Center for Memory and Cognition Research, 
which  is  housed  at Wake  Forest  University  School  of 
Medicine. The Cognition Coordinating Center staff work 
closely with the Administrative Coordinating Center and 
DMAQC to implement all cognition-related aspects of the 
trial.
Data Safety Monitoring Board.—A Data Safety Monitoring 
Board has been appointed by the National Institute on 
Aging.
Discussion
The LIFE Study will compare the effects of its two life-
style interventions on the development of major mobility 
disability in sedentary older adults who have functional lim-
itations at baseline. When completed, the LIFE Study will 
be the largest and the longest lifestyle intervention trial 
focused on older adults. Both interventions are fairly simple 
to implement, require minimal equipment, and can be deliv-
ered within community settings. Results of the LIFE Study 
are likely to have significant public health implications.
The benefits of PA in older populations have been dem-
onstrated primarily in the context of changes in intermedi-
ate measures of physiologic impairments, such as strength 
and balance, or functional limitations, such as gait speed 
and stair-climbing performance. No prior clinical trials have 
demonstrated definitively that any lifestyle intervention pre-
vents the onset of major mobility disability in older persons 
who are nondisabled. The Centers for Disease Control 
recently highlighted the importance of expanding research 
on the benefits of PA to include a broader range of disability 
and quality-of-life measures (84). In addition, the Physical 
Activity  Guidelines  for  Americans  Committee  report   
concluded “future research needs to focus on large-scale 
well-designed trials to ascertain whether PA programs can 
prevent disability and role limitations as people advance 
into old age” (83).
Several large randomized controlled trials have demon-
strated the problems of relying exclusively on observational 
data and intermediate or surrogate outcomes. These studies 
include  the  pharmacological  treatment  of  arrhythmias 
(85), hypertension (86), and postmenopausal hormone ther-
apy (87,88). These studies suggest that observational data 
and  trials  using  surrogate  outcomes  may  be  misleading 
with regard to prevention of major clinical events. The 
LIFE Study will fill a critical knowledge gap on the ability 
of a lifestyle intervention to delay or prevent disability in 
older adults.
Selection of the Primary Outcome
Continuous measures of function are sensitive indicators 
of the physiologic effects of interventions. These have been 
useful for guiding the refinement of exercise interventions. 
However, to move the field forward and create a clear mes-
sage for public health and clinical practice, the LIFE Study 
is using an objectively measured outcome that identifies the 
ability to perform a critical task of daily living and has good 
measurement characteristics (53). Major mobility disability 
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fits this description and encompasses important aspects 
of independent living.
Preserving the ability to walk 400 m, a proxy for commu-
nity ambulation, is central to maintaining a high quality 
of life, including the ability to carry out many activities that 
are needed to be fully independent. In addition, mobility 
loss predicts adverse outcomes including morbidity, institu-
tionalization, and mortality (7,89–94).
Dose of PA
Based on LIFE-P, the researchers have made several 
enhancements to the PA intervention to improve the effi-
cacy of the program and foster adherence over the planned 
intervention  period.  In  LIFE-P,  the  researchers  observed 
that most participants had difficulty transitioning through 
the varied frequency of the center-based intervention atten-
dance. In particular, the reduction in group session atten-
dance from three times per week in the adoption phase to   
two times per week in the transition phase and then to one 
time per week (optional) in the maintenance phase was not 
well received by the participants. Therefore, the interven-
tion sessions are held two times per week throughout the 
length of the trial, with the center-based sessions combined, 
from the beginning of the intervention, with participation in 
individualized home-based PA that progresses up to 3–4 d/wk 
by the end of the adoption phase. This modification will 
likely further enhance adherence to the intervention across 
the longer trial duration of the LIFE Study and minimize 
participant confusion. Data from both PA and weight con-
trol trials support the concept that more frequent contact 
promotes sustained adherence (95–97). It additionally pro-
vides a means for safely and effectively restarting those 
participants encountering health or related difficulties that 
temporarily prevent them from participating in regular PA.
Maintaining adherence represents a major challenge in 
long-term PA trials involving older adults due to illness, 
caregiving, environmental barriers, etc. (98,99). LIFE-P had 
a 65% PA attendance rate at 6 months follow-up (52). Many 
randomized trials of activity in older adults lasting several 
months to >1 year have achieved adherence rates in this 
same range (50%–60%), including several intervention 
studies  that  enrolled  participants  for  18  months  up  to   
3 years (38,100,101). These previous studies have observed 
declining adherence rates that appear to stabilize between 
12 and 18 months of the intervention. For example, the 
Diabetes Prevention Program trial reported a decline in 
participants’ achievement of their proposed PA goal (150 
min/wk) from 74% at 24 weeks to 58% at their most recent 
study  visit  (102).  Despite  these  less-than-optimal  and   
declining adherence rates, these studies all demonstrated 
significant benefits of PA on functional outcomes and health. 
Recently, an age-stratified analysis of the results of the 
Diabetes Prevention Program revealed that adherence to the 
PA component of the intensive lifestyle intervention (≥150 
min/wk of PA) was achieved in 48% of participants 60–85 
years compared with 38% and 34% in 45- to 59-year-olds 
and 25- to 44-year-olds, respectively, over the approximate 
3-year  follow-up  (103).  More  importantly,  the  observed 
level of adherence to the intensive lifestyle intervention in 
the older cohort resulted in a significant decrease in the 
development of type II diabetes mellitus in this group. 
Adherence rates to pharmacological interventions have, in 
general, been of a similar magnitude as those the researchers 
expect for PA in the LIFE Study (104–106).
In conclusion, definitive evidence from Phase 3 random-
ized controlled trials of whether a sustained program of life-
style intervention can prevent or delay the development of 
late-life disability is lacking. The LIFE Study is a Phase 3 
randomized controlled trial designed to compare the effi-
cacy of a structured PA program with a SA health education 
program and is expected to influence health care policy on 
the successful prevention and treatment of disability among 
older adults in the future. An especially novel feature of the 
LIFE Study is its inclusion of a robust set of cognitive func-
tion measures to assess the impact of the intervention   
on this important secondary outcome. If PA is shown to 
prevent mobility disability, research and training activities 
aimed  at  the  translation,  including  community-based   
dissemination, and integration of this type of behavioral 
intervention into medical care of older persons would be of 
particular importance.
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